-

MedImpact Unveils Innovative PMPM Guarantee Model

New program bundles key cost-saving services into a single, predictable price—and puts 100% of MedImpact’s administrative fee at risk to back its guarantee

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent pharmacy benefits technology and health solutions provider, today announced the launch of MedImpact OnePrice™, a new approach to prescription drug cost containment that offers clients a predictable, transparent, and performance-backed Per Member, Per Month (PMPM) pricing model. Unlike other guarantees on the market, MedImpact stands firmly behind its commitment—putting its entire administrative fee at risk to ensure clients meet the guaranteed PMPM targets.

MedImpact unveils innovative PMPM guarantee model

Share

“The MedImpact OnePrice program is our answer to the market’s demand for cost certainty, accountability, and savings,” said Zach Johnson, MedImpact Executive Vice President. “We believe so strongly in the effectiveness of our clinical and cost savings strategies that we’re putting our entire administrative fee on the line.”

MedImpact OnePrice is a bundle of the company’s most effective cost containment solutions designed to help self-insured health plans take control of rising pharmacy costs without sacrificing clinical effectiveness, access, or care. MedImpact OnePrice is projected to save clients up to 20% in costs, while improving budgeting and planning.

Key Features:

  • 100% Pass-Through: Clients receive full transparency into rebates and manufacturer discounts
  • Financial Predictability: A guaranteed monthly PMPM eliminates cost surprises and simplifies budget planning
  • Transparent, Fixed Administrative Fees: MedImpact’s clearly defined administrative fee covers all services, with 100% of this fee tied to meeting the PMPM pricing target
  • Advanced Cost Containment: Combines a full suite of savings programs—including formulary alignment, utilization management, copay assistance (for specialty and non-specialty drugs), an integrated discount card, and high-cost generic drug management
  • Annual Reconciliation: PMPM rates are trued up at year-end to maintain fairness and transparency

The MedImpact OnePrice guarantee is based on an analysis of the client’s claims over a 12-month period adjusted annually based on drug and population trends, new drugs entering the market, and other factors.

“Accountability and transparency are touchstones of our company,” continued Johnson. “MedImpact OnePrice is our way of proving it—by aligning our fees with client success to deliver real value.”

About MedImpact

San Diego-based MedImpact Healthcare Systems, Inc. is the nation’s largest independent health solutions, technology, and pharmacy benefit management provider. For 35 years, MedImpact has helped commercial and government healthcare payers improve member health, manage benefits, and reduce drug costs. Today, MedImpact serves more than 20 million members and processes more than $40 billion in pharmacy transactions annually. To learn more, visit us online, follow us on LinkedIn, or contact us at info@MedImpact.com.

Contacts

Media Contact
Jennifer Kroll, jkroll@jwa.co

MedImpact


Release Versions

Contacts

Media Contact
Jennifer Kroll, jkroll@jwa.co

Social Media Profiles
More News From MedImpact

MedImpact Unveils Refreshed Corporate Identity

SAN DIEGO--(BUSINESS WIRE)--MedImpact Healthcare Systems, Inc., the nation’s largest independent provider of health solutions, technology, and pharmacy benefit management services, today unveiled a refreshed corporate brand that reflects the company’s evolution and mission to build a tech-enabled, clinically driven, and highly personalized approach to healthcare. “Healthcare payers today must navigate a fragmented, inflexible, and opaque system that limits their ability to act on what matters m...

MedImpact’s MedEmpower Fuel™ Receives PBMI Excellence Award

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent provider of pharmacy benefit, health, and technology solutions, announced today that its MedEmpower Fuel™ app has been honored with the Pharmacy Benefit Management Institute’s (PBMI) Excellence Award. “MedEmpower Fuel is built on the principle that addressing the root causes of high-cost conditions is as important as managing them after they develop,” said Zach Johnson, Executive Vice President at MedImpact. “Fuel is about...

MedImpact Offers Low Cost, Unbranded Ustekinumab-aekn Biosimilar to Any Specialty Pharmacy in the US

SAN DIEGO--(BUSINESS WIRE)--MedImpact Holdings Inc. today announced that it will have access to an unbranded biosimilar ustekinumab-aekn at a significantly lower cost than the reference Stelara® (ustekinumab). The biosimilar, distributed by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., will be available for direct purchase from MedImpact’s preferred partner, Birdi, Inc., by any licensed specialty pharmacy. “Today, a drug’s cost rises at each step in the supply chain,” said Arpit Patel,...
Back to Newsroom